ALBERT BOURLA - 14 Nov 2025 Form 4 Insider Report for PFIZER INC (PFE)

Role
Chairman & CEO, Director
Signature
/s/ Shanice A. Reid, by power of atty., for Albert Bourla
Issuer symbol
PFE
Transactions as of
14 Nov 2025
Transactions value $
$601
Form type
4
Filing time
17 Nov 2025, 21:02:04 UTC
Previous filing
03 Nov 2025
Next filing
02 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BOURLA ALBERT Chairman & CEO, Director 66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK /s/ Shanice A. Reid, by power of atty., for Albert Bourla 17 Nov 2025 0001595703

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Phantom Stock Units SSP Award $601 +24 +0% $25.06 744K 14 Nov 2025 Common Stock 24 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each unit represents one phantom share of common stock.
F2 These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.